ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0730

Dysmorphic vs. Isomorphic Hematuria in the Diagnostic Approach to Glomerular Diseases

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Bedoya, Hector Luis, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Bermejo Garcia, Sheila, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Sanchez, Jorge Alexander, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • López-Martínez, Marina, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Sans Atxer, Laia, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Zamora Carrillo, Jorge Ivan, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Patricio-Liébana, Marc, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Ramos, Natalia, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Nunez-Delgado, Sara, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Agraz, Irene, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
  • Soler, Maria Jose, Hospital Universitari Vall d'Hebron, Barcelona, CT, Spain
Background

Dysmorphic hematuria has been associated with glomerulonephritis(GN).The detection of dysmorphism is a qualitative analysis with high specificity and variable sensitivity.The objetive was to evaluate patients diagnosed with GN by assessing the prevalence of dysmorphic and isomorphic microhematuria, as well as factors associated with the presence of dysmorphic hematuria.

Methods

We analyzed patients diagnosed of glomerulonephritis(GN) at our hospital.Clinical and laboratory data were collected, including the presence of isomorphic or dysmorphic hematuria and evaluated differences between groups.

Results

we included 243 patients: 128 males(52.7%), mean age 54.8(±19)years; 50.2%(n=122) were hypertensive. At the time of renal biopsy, mean serum creatinine was1.94 mg/dl, estimated glomerular filtration rate(eGFR)33[14-68]mL/min and albumin to creatinine ratio was 500mg/g. The most common indication for renal biopsy was acute kidney injury and diagnoses was IgA nephropathy. Hematuria was observed in 224 patients(92.2%), of whom 77(34.3%) were dysmorphic.
A higher percentage of dysmorphism was detected in IgA nephropathy. Lower prevalence of dysmorphic hematuria were detected in lupus nephritis class IV, thrombotic microangiopathy and crescentic GNs.A higher frequency of dysmorphism was noted in patients whose renal biopsy was indicated for proteinuria and hematuria or isolated hematuria(p<0.001). Younger patients(p=0.015), better renal function(p=0.013) and lower level of proteinuria(p=0.017) demonstrated a higher incidence of dysmorphism. Patients without dysmorphism had a higher prevalence of ischemic heart disease(p=0.038) and hypertension(p=0.046).In the logistic regression analysis adjusted for previous variables, nephrotic proteinuria(1.5–29.2OR:6.5,p=0.014) and better renal function(0.79–0.99 OR:0.89,p=0.039) were associated to dysmorphic hematuria. A ROC curve with an area under the curve of 0.659(0.586–0.733p<0.001) was obtained.

Conclusion

In our cohort of patients diagnosed with GN, dysmorphism was detected in less than half of the cases, with a sensitivity of 77.2% and a specificity of 100%. The presence of nephrotic proteinuria and better renal function were associated with the presence of dysmorphic hematuria.

Digital Object Identifier (DOI)